Are the Effects of Tamoxifen on the Serum Lipid Profile Modified by Apolipoprotein E Phenotypes?

Moses Elisaf(University of Ioannina), Sonia-Athena P. Karabina(Laboratoire de Biochimie), Eleni Bairaktari(University of Ioannina), Nikolaos Pavlidis(University Hospital of Ioannina), Alexandros D. Tselepis(University of Ioannina), C. Nicolaides(University Hospital of Ioannina)
Oncology
January 1, 2002
10.1159/000048256
Cited by 25

Related Papers

The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement
|Metabolism|2017|251
The Critical Role of the Branched Chain Amino Acids (BCAAs) Catabolism-Regulating Enzymes, Branched-Chain Aminotransferase (BCAT) and Branched-Chain α-Keto Acid Dehydrogenase (BCKD), in Human Pathophysiology
|International Journal of Molecular Sciences|2022|214
“European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses
|Current Vascular Pharmacology|2011|197
Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2010|166
Primary gastrointestinal non-Hodgkin's lymphoma: A clinicopathologic study of 128 cases in Greece. A Hellenic Cooperative Oncology Group study (HeCOG)
|Leukemia & lymphoma/Leukemia and lymphoma|2006|160